In conclusion, the partial loss of SMARCB1/INI1, secondary to heterozygous deletion and/or copy number gain of SMARCB1, can be identified by immunohistochemistry in a significant portion of conventional chordomas, and is not peculiar of aggressive cases. The gene discussed is SMARCB1; the disease is chordoma.